Madrigal Pharmaceuticals (MDGL) Return on Assets (2011 - 2026)

Madrigal Pharmaceuticals (MDGL) has 16 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.

• Return on Assets for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Assets slipped to 0.0% in Q1 2026 per MDGL's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Assets peaked at 0.0% in Q4 2025 and troughed at 0.01% in Q3 2022.
• A 5-year average of 0.01% and a median of 0.01% in 2024 frame the typical range for Return on Assets.
• The sharpest annual moves came in 2022 and 2024: Return on Assets decreased 1 bps in 2022, then rose 1 bps in 2024.
• A 5-year view of Return on Assets shows it stood at 0.01% in 2022, then rose by 25 bps to 0.01% in 2023, then jumped by 48 bps to 0.0% in 2024, then soared by 51 bps to 0.0% in 2025, then slipped by 12 bps to 0.0% in 2026.
• Business Quant data shows MDGL's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.